AN IN-VIVO MODEL FOR RECEPTOR TYROSINE KINASE AUTOCRINE PARACRINE ACTIVATION - AUTO-STIMULATED KIT RECEPTOR ACTS AS A TUMOR-PROMOTING FACTOR IN PAPILLOMAVIRUS-INDUCED TUMORIGENESIS/
G. Kondoh et al., AN IN-VIVO MODEL FOR RECEPTOR TYROSINE KINASE AUTOCRINE PARACRINE ACTIVATION - AUTO-STIMULATED KIT RECEPTOR ACTS AS A TUMOR-PROMOTING FACTOR IN PAPILLOMAVIRUS-INDUCED TUMORIGENESIS/, Oncogene, 10(2), 1995, pp. 341-347
Constitutive overactivation of growth factor receptors through autocri
nelparacrine mechanisms occurs frequently in cancer cells and are thou
ght to play a critical role in carcinogenesis. In the present report,
we propose a refined in vivo model which explains the significance of
these mechanisms in tumour development. We have previously established
transgenic mouse lines containing human papillomavirus type 16 (HPV16
) E6E7 oncogenes, in male mice of which a Leydig cell tumor developes
with a very high incidence, Not only HPV transgene but also the c-kit
proto-oncogene receptor tyrosine kinase and its ligand Steel Factor (S
LF) were coexpressed in all tumors analysed. This coexpression of c-ki
t/SLF was also found in two other Leydig cell tumor lines. Moreover, t
he proliferation of transgenic tumor cells was attenuated by treatment
with a c-kit neutralizing antibody in vitro, strongly suggesting that
tumorigenesis is closely related to stimulation of receptors through
ligand induction, To confirm the significance of these findings, a def
ective mutation of the SLF gene in a laboratory mouse, the Steel-Dicke
y (Sld) mutation, was introduced into a line of transgenic mice showin
g 100% incidence of the tumor. In Sl(d)-E6E7 transgenic mice, tumorige
nesis was initiated but numbers of tumor cells were markedly reduced c
ompared with transgenic mice carrying both wild type SLP allele, showi
ng that c-kit activation through the induction of SLF is essential for
testicular tumorigenesis, especially in tumour promotion. This transg
enic mice system should be a useful in vivo model for clarifying the i
mplication of growth factor autostimulation in carcinogenesis.